Table 4 Differences in clinical signs of vaccinated and unvaccinated moribund and vaccinated survivors Atlantic salmon coinfected with C. rogercresseyi and P. salmonis.

From: Host genetic variation explains reduced protection of commercial vaccines against Piscirickettsia salmonis in Atlantic salmon

Type of lesion or alteration

Presence of alterations

Number of fish

Proportion

X-squared UM − VM

X-squared VM − VS

df

p-valuea UM—VM

p-valuea VM—VS

UM

VM

VS

UM

VM

VS

Skin congestion

No

4

5

1

0.20

0.25

0.05

0

1.7647

1

1

0.184

Yes

16

15

19

0.80

0.75

0.95

     

Desquamation

No

4

4

5

0.20

0.20

0.25

0

0

1

1

1

Yes

16

16

15

0.80

0.80

0.75

     

Skin ecchymosis

No

11

9

8

0.55

0.45

0.40

0.1

0

1

0.7518

1

Yes

9

11

12

0.45

0.55

0.60

     

Gill paleness

No

0

0

1

0.00

0.00

0.05

0

0

1

1

1

Yes

20

20

19

1.00

1.00

0.95

     

Gill mucus

No

0

0

11

0.00

0.00

0.55

0

12.539

1

1

0.0003985

Yes

20

20

9

1.00

1.00

0.45

     

Gill melanomacrophagues

No

5

4

10

0.25

0.20

0.50

0

2.7473

1

1

0.09742

Yes

15

16

10

0.75

0.80

0.50

     

White hepatic nodules

No

0

1

12

0.00

0.05

0.60

0

11.396

1

1

0.000736

Yes

20

19

8

1.00

0.95

0.40

     

Hepatomegaly

No

17

18

19

0.85

0.90

0.95

0

0

1

1

1

Yes

3

2

1

0.15

0.10

0.05

     

Spleen paleness

No

0

0

0

0.00

0.00

0.00

0

0

1

1

1

Yes

20

20

20

1.00

1.00

1.00

     

Splenomegaly

No

1

0

0

0.05

0.00

0.00

0

0

1

1

1

Yes

19

20

20

0.95

1.00

1.00

     
  1. U unvaccinated; V vaccinated; M moribund; and S survivors.
  2. ap-values were obtained from non-parametric chi-square test to compare proportions.